March 1, 2026 · Form 4 insider transaction
Crombez Eric bought 11,643 shares of Ultragenyx Pharmaceutical Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents shares of common stock which previously granted performance stock units were converted on March 1, 2026 upon certification of the performance metrics.